540204 — Eiko Lifesciences Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹679.51m
- IN₹638.74m
- IN₹183.21m
- 24
- 19
- 44
- 14
2020 March 31st | C2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 0.952 | 69.4 | 4.46 | 6.12 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0 | 34.1 | 45.6 | 71.1 |
Total Inventory | ||||
Total Other Current Assets | ||||
Total Current Assets | 1 | 107 | 124 | 93 |
Net Property, Plant And Equipment | 3.09 | 2.48 | 143 | 139 |
Long Term Investments | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 57.6 | 166 | 349 | 310 |
Accounts Payable | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.842 | 39.6 | 60.1 | 12 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Total Other Liabilities | ||||
Total Liabilities | 2.8 | 40.9 | 62.6 | 16.2 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 54.8 | 125 | 286 | 294 |
Total Liabilities & Shareholders' Equity | 57.6 | 166 | 349 | 310 |
Total Common Shares Outstanding |